Live Breaking News & Updates on Novartis Ag Stock Exchange
Stay updated with breaking news from Novartis ag stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OPINION CHANGECHANGE IN OPINIONAdd vs ReduceApart from the strong Q1 23 operating momentum that resulted in an upgrade to the 2023 guidance, 1/ positive phase III results for Kisqali in early stage. | April 26, 2023 ....
Positive opinion paves way for first new treatment option in hidradenitis suppurativa in nearly a decade Committee for Medicinal Products for Human Use opinion based on robust Phase III data. | April 26, 2023 ....
Novartis AG on Tuesday posted slightly higher net profit and sales for the first quarter of the year, beating analysts expectations, and raised its guidance for the full. | April 25, 2023 ....
Analyst Peter Welford from Jefferies research considers the stock attractive and recommends it with a Buy rating. The target price remains unchanged at CHF 100. | April 25, 2023 ....
Novartis on Tuesday raised its full-year earnings outlook after cutting costs, a breast cancer drug trial success and progress in boosting output of a radiotherapy drug against prostate cancer. . | April 25, 2023 ....